+31.0%
MRNA vs AMDL
+115.6%
-84.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | AMDL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -6.7% | +7.4% | +1.4% |
| 7D | -8.2% | +20.7% | -28.9% | -10.3% |
| 30D | +125.6% | +9.4% | +116.1% | +121.0% |
| 3M | +197.1% | +5.6% | +191.4% | +181.3% |
| 6M | +148.5% | +340.3% | -191.8% | +81.8% |
| YTD | +363.3% | +253.6% | +109.6% | +242.6% |
| 1Y | +462.0% | +443.4% | +18.6% | +271.5% |
| All | +31.0% | +115.6% | -84.5% | -18.1% |
Cumulative growth
Daily Returns
Daily percentage return beside AMDL.
Daily Out/Under-Performance
Portfolio return minus AMDL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMDL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded AMDL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling